DICLOFENAC SODIUM tablet, delayed release

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

DICLOFENAC SODIUM (UNII: QTG126297Q) (DICLOFENAC - UNII:144O8QL0L1)

Available from:

NuCare Pharmaceuticals,Inc.

INN (International Name):

DICLOFENAC SODIUM

Composition:

DICLOFENAC SODIUM 75 mg

Administration route:

ORAL

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Carefully consider the potential benefits and risks of Diclofenac Sodium Delayed-release Tablets and other treatment options before deciding to use Diclofenac Sodium Delayed-release Tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Diclofenac Sodium Delayed-release Tablets, are indicated: - For relief of signs and symptoms of osteoarthritis - For relief of signs and symptoms of rheumatoid arthritis - For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis Diclofenac Sodium Delayed-release Tablets are contraindicated in patients with known hypersensitivity to Diclofenac. Diclofenac Sodium Delayed-release Tablets should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see WARNINGS, Anaphyla

Product summary:

75 mg : round, Light brown, enteric-coated tablets P 75 imprinted on one side in black ink and plain on the reverse side are NDC 66267-071-14 Bottles of 14 NDC 66267-071-20 Bottles of 20 Store at 20°-25°C (68°-77°F) (see USP Controlled Room Temperature). Protect from moisture. Dispense in a tight, light-resistant container. Manufactured by: UNIQUE PHARMACEUTICAL LABORATORIES. (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Mumbai 400 030, India. Distributed by: PACK Pharmaceuticals, LLC Buffalo Grove, IL 60089

Authorization status:

Abbreviated New Drug Application

Patient Information leaflet

                                NuCare Pharmaceuticals,Inc.
----------
MEDICATION GUIDE for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
(See the end of this Medication Guide for a list of prescription NSAID
medicines.)
WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT
MEDICINES CALLED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
(NSAIDS)?
NSAID medicines may increase the chance of a heart attack or stroke
that can lead to death. This chance
increases:
•
with longer use of NSAID medicines
•
in people who have heart disease
NSAID medicines should never be used right before or after a heart
surgery called a “coronary artery
bypass graft (CABG).”
NSAID medicines can cause ulcers and bleeding in the stomach and
intestines at any time during
treatment. Ulcers and bleeding:
•
can happen without warning symptoms
•
may cause death
The chance of a person getting an ulcer or bleeding increases with:
•
taking medicines called “corticosteroids” and “anticoagulants”
•
longer use
•
smoking
•
drinking alcohol
•
older age
•
having poor health
NSAID medicines should only be used:
•
exactly as prescribed
•
at the lowest dose possible for your treatment
•
for the shortest time needed
WHAT ARE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)?
NSAID medicines are used to treat pain and redness, swelling, and heat
(inflammation) from medical
conditions such as:
•
different types of arthritis
•
menstrual cramps and other types of short-term pain
WHO SHOULD NOT TAKE A NON-STEROIDAL ANTI-INFLAMMATORY DRUG
(NSAID)?
Do not take an NSAID medicine:
•
if you had an asthma attack, hives, or other allergic reaction with
aspirin or any other NSAID
medicine
•
for pain right before or after heart bypass surgery
Tell your healthcare provider:
•
about all your medical conditions.
•
about all of the medicines you take. NSAIDs and some other medicines
can interact with each
other and cause serious side effects. Keep a list of your medicines to
show to your healthcare
provider and pharmacist.
•
if you are pregnant. NSAID medicines
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                DICLOFENAC SODIUM- DICLOFENAC SODIUM TABLET, DELAYED RELEASE
NUCARE PHARMACEUTICALS,INC.
----------
DICLOFENAC SODIUM DELAYED-RELEASE TABLETS USP, 25 MG, 50 MG AND 75 MG
Rx only
CARDIOVASCULAR RISK
NSAIDs may cause an increased risk of serious cardiovascular
thrombotic
events, myocardial infarction, and stroke, which can be fatal. This
risk may
increase with duration of use. Patients with cardiovascular disease or
risk
factors for cardiovascular disease may be at greater risk. (See
WARNINGS.)
Diclofenac sodium delayed-release tablets are contraindicated for the
treatment
of perioperative pain in the setting of coronary artery bypass graft
(CABG)
surgery (see WARNINGS).
GASTROINTESTINAL RISK
NSAIDs cause an increased risk of serious gastrointestinal adverse
events
including inflammation, bleeding, ulceration, and perforation of the
stomach or
intestines, which can be fatal. These events can occur at any time
during use
and without warning symptoms. Elderly patients are at greater risk for
serious
gastrointestinal events. (See WARNINGS).
DESCRIPTION
Diclofenac Sodium Delayed-release Tablets are a benzene-acetic acid
derivative.
Diclofenac Sodium Delayed-release Tablets are available as
delayed-release (delayed-
release) tablets of 25 mg or 50 mg for oral administration. The
chemical name is 2-[(2,6-
dichlorophenyl)amino] benzeneacetic acid, monosodium salt. The
molecular weight is
318.14. Its molecular formula is C
H
Cl
NNaO
, and it has the following structural
formula
The inactive ingredients in Diclofenac Sodium Delayed-release Tablets
include: lactose
(monohydrate), microcrystalline cellulose, croscarmellose sodium,
povidone, talc,
magnesium stearate, methacrylic acid copolymer, polyethylene glycol,
opadry brown
14
10
2
2
(Titanium dioxide, hypromellose, polyethylene glycol, iron oxide red,
iron oxide yellow)
and purified water.
CLINICAL PHARMACOLOGY
PHARMACODYNAMICS
Diclofenac Sodium Delayed-release Tablets, are a nonsteroidal
anti-inflammatory drug
(NSAID) that exhibits anti-inflammatory, analgesic, and antip
                                
                                Read the complete document
                                
                            

Search alerts related to this product